During the past decade, Medical Center Nadezhda Clinical EOOD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Center Nadezhda Clinical EOOD" #1 sponsor was "Pfizer" with 2 trials, followed by "Amgen" with 1 trials sponsored, "BeiGene" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Institut de Recherches Internationales Servier" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center Nadezhda Clinical EOOD" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center Nadezhda Clinical EOOD" are "Breast Cancer" (1 trials), "Cervical Cancer" (1 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials), "Melanoma" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Medical Center Nadezhda Clinical EOOD" in a lesser frequency.

Most popular intervention types in "Medical Center Nadezhda Clinical EOOD" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Encorafenib" (2 trials), "Placebo" (2 trials), "5-FU" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center Nadezhda Clinical EOOD" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medical Center Nadezhda Clinical EOOD". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Medical Center Nadezhda Clinical EOOD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center Nadezhda Clinical EOOD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".